Abstract
Stroke is a life-altering neurological event that frequently results in persistent motor deficits, speech impairment, cognitive decline, and reduced quality of life. It occurs when cerebral blood flow is interrupted or compromised and is broadly categorized into ischemic stroke, hemorrhagic stroke, and transient ischemic attack. Current standards of care including thrombolytic therapy, surgical intervention, and structured rehabilitation aim to restore perfusion, limit neurological damage, and optimize functional recovery. While these interventions have significantly improved acute survival, outcomes remain suboptimal in many patients, particularly those with extensive neurological injury (Yang et al., 2024). Growing scientific interest has therefore turned toward integrative strategies that complement conventional treatment. Emerging evidence suggests that targeted nutritional and phytochemical interventions such as vitamins, antioxidants, and anti-inflammatory compounds may influence key molecular pathways involved in oxidative stress, neuroinflammation, mitochondrial dysfunction, and neuroplasticity (Liang et al., 2022). This paper presents the case of a 62-year-old male stroke patient who underwent conventional therapy augmented with a structured natural medicine protocol. Through this case analysis, we explore how evidence-informed integrative approaches may support neurological recovery, reduce secondary complications, and enhance overall quality of life. The findings suggest that incorporating well-designed natural formulations into post-stroke care may provide a valuable adjunct to standard rehabilitation strategies.
References
- Ahsan A., et al. “Natural compounds modulate the autophagy with potential implication of stroke”. Acta Pharmaceutica Sinica B 11.7 (2021): 1708-1720.
- Alahmari LA. “Dietary fiber influences overall health, with an emphasis on CVD, diabetes, obesity, colon cancer, and inflammation”. Frontiers in Nutrition 11 (2024): 1510564.
- Carvalho C and Moreira PI. “Oxidative stress: A major player in cerebrovascular alterations associated with neurodegenerative events”. Frontiers in Physiology 9 (2018): 806.
- Chugh C. “Acute ischemic stroke: Management approach”. Indian Journal of Critical Care Medicine 23.Suppl 2 (2019): S140-S146.
- Ciancarelli I., et al. “Neuronutrition and its impact on post-stroke neurorehabilitation: Modulating plasticity through diet”. Nutrients 16.21 (2024): 3705.
- Cichon N., et al. “The role of supplementation with natural compounds in post-stroke patients”. International Journal of Molecular Sciences 22.15 (2021): 7893.
- Cui P., et al. “Vitamin D and ischemic stroke association, mechanisms, and therapeutics”. Ageing Research Reviews (2024): 102244.
- Gaire BP. “Herbal medicine in ischemic stroke: Challenges and prospective”. Chinese Journal of Integrative Medicine 24 (2018): 243-246.
- Goyal R., et al. “Natural products in the management of neurodegenerative diseases”. Nutrition & Metabolism 21.1 (2024): 26.
- Herpich F and Rincon F. “Management of acute ischemic stroke”. Critical Care Medicine 48.11 (2020): 1654-1663.
- Jelinek M, Jurajda M and Duris K. “Oxidative stress in the brain: Basic concepts and treatment strategies in stroke”. Antioxidants 10.12 (2021): 1886.
- Kakarla R, Vinjavarapu LA and Krishnamurthy S. “Diet and nutraceuticals for treatment and prevention of primary and secondary stroke”. Neurochemistry International (2024): 105823.
- Kamal FZ., et al. “The role of potential oxidative biomarkers in the prognosis of acute ischemic stroke”. International Journal of Molecular Sciences 24.7 (2023): 6389.
- Li C, Sun T and Jiang C. “Recent advances in nanomedicines for the treatment of ischemic stroke” (2021).
- Li Z., et al. “The role of oxidative stress in acute ischemic stroke-related thrombosis”. Oxidative Medicine and Cellular Longevity (2022): 8418820.
- Liang H., et al. “Editorial: Herbal medicines in managing stroke and neurodegenerative diseases, volume II”. Frontiers in Pharmacology 13 (2022): 1059848.
- Mancin S., et al. “Assessment of malnutrition risk in post-stroke patients: A systematic literature review”. Scientific results of biomedical research 9.4 (2023): 524-543.
- Marek K., et al. “The role of vitamin D in stroke prevention”. Nutrients 14.13 (2022): 2761.
- Mosconi MG and Paciaroni M. “Treatments in ischemic stroke: Current and future”. European Neurology 85.5 (2022): 349-366.
- Nogueira-de-Almeida CA., et al. “Neuronutrients and central nervous system: A systematic review”. Central Nervous System Agents in Medicinal Chemistry 23.1 (2023): 1-12.
- Paul S and Candelario-Jalil E. “Emerging neuroprotective strategies for ischemic stroke”. Experimental Neurology 335 (2021): 113518.
- Phipps MS and Cronin CA. “Management of acute ischemic stroke”. BMJ 368 (2020).
- Song G., et al. “The role of nanomaterials in stroke treatment: Targeting oxidative stress”. Oxidative Medicine and Cellular Longevity (2021): 8857486.
- Tang X., et al. “Vitamin C intake and ischemic stroke”. Frontiers in Nutrition 9 (2022): 935991.
- Tao T., et al. “Natural medicine in neuroprotection for ischemic stroke”. Pharmacology & Therapeutics 216 (2020): 107695.
- Yang J, Yu B and Zheng J. “Natural herbal extract roles and mechanisms in treating cerebral ischemia”. Frontiers in Pharmacology 15 (2024): 1424146.
- Yarlagadda K, Ma N and Doré S. “Vitamin D and stroke: Effects on incidence, severity, and outcome”. Frontiers in Neurology 11 (2020): 384.
- Zhan F., et al. “Higher oxidative balance score decreases risk of stroke in US adults”. Frontiers in Cardiovascular Medicine 10 (2023): 1264923.
- Zielińska-Nowak E., et al. “Nutritional supplements and neuroprotective diets in post-stroke rehabilitation”. Nutrients 13.8 (2021): 2704.
- Zhu T., et al. “Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke”. Biomedicine & Pharmacotherapy 148 (2022): 112719.
- Zhu Z., et al. “Plasma amino acid neurotransmitters and ischemic stroke prognosis”. The American Journal of Clinical Nutrition 118.4 (2023): 754-762.